| The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management A Dignass, G Van Assche, JO Lindsay, M Lémann, J Söderholm, ... Journal of Crohn's and Colitis 4 (1), 28-62, 2010 | 1772 | 2010 |
| The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis G Van Assche, A Dignass, J Panes, L Beaugerie, J Karagiannis, M Allez, ... Journal of Crohn's and Colitis 4 (1), 7-27, 2010 | 1354 | 2010 |
| Reduced Paneth cell α-defensins in ileal Crohn's disease J Wehkamp, NH Salzman, E Porter, S Nuding, M Weichenthal, RE Petras, ... Proceedings of the National Academy of Sciences 102 (50), 18129-18134, 2005 | 1304 | 2005 |
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management A Dignass, JO Lindsay, A Sturm, A Windsor, JF Colombel, M Allez, ... Journal of Crohn's and Colitis 6 (10), 991-1030, 2012 | 1302 | 2012 |
| NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression J Wehkamp, J Harder, M Weichenthal, M Schwab, E Schäffeler, M Schlee, ... Gut 53 (11), 1658-1664, 2004 | 1133 | 2004 |
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations G Van Assche, A Dignass, W Reinisch, CJ van der Woude, A Sturm, ... Journal of Crohn's and Colitis 4 (1), 63-101, 2010 | 947 | 2010 |
| European evidence based consensus on the diagnosis and management of Crohn’s disease: current management SPL Travis, EF Stange, M Lémann, T Öresland, Y Chowers, A Forbes, ... Gut 55 (suppl 1), i16-i35, 2006 | 937 | 2006 |
| A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease WJ Sandborn, BG Feagan, SB Hanauer, H Lochs, R Löfberg, ... Gastroenterology 122 (2), 512-530, 2002 | 872 | 2002 |
| European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis EF Stange, SPL Travis, S Vermeire, C Beglinger, L Kupcinkas, K Geboes, ... Gut 55 (suppl 1), i1-i15, 2006 | 869 | 2006 |
| European evidence-based consensus on the management of ulcerative colitis: current management SPL Travis, EF Stange, M Lémann, T Øresland, WA Bemelman, ... Journal of Crohn's and Colitis 2 (1), 24-62, 2008 | 730 | 2008 |
| European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis EF Stange, SPL Travis, S Vermeire, W Reinisch, K Geboes, ... Journal of Crohn's and Colitis 2 (1), 1-23, 2008 | 728 | 2008 |
| A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon K Fellermann, DE Stange, E Schaeffeler, H Schmalzl, J Wehkamp, ... The American Journal of Human Genetics 79 (3), 439-448, 2006 | 713 | 2006 |
| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 699 | 2009 |
| NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium J Wehkamp, J Harder, K Wehkamp, BW Meissner, M Schlee, C Enders, ... Infection and immunity 72 (10), 5750-5758, 2004 | 680 | 2004 |
| Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. KE Suckling, EF Stange Journal of Lipid Research 26 (6), 647-671, 1985 | 648 | 1985 |
| Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1 BO Schroeder, Z Wu, S Nuding, S Groscurth, M Marcinowski, J Beisner, ... Nature 469 (7330), 419-423, 2011 | 555 | 2011 |
| Extraintestinal manifestations and complications in inflammatory bowel diseases KS Rothfuss, EF Stange, KR Herrlinger World journal of gastroenterology: WJG 12 (30), 4819, 2006 | 530 | 2006 |
| Intestinal barrier in inflammatory bowel disease L Antoni, S Nuding, J Wehkamp, EF Stange World journal of gastroenterology: WJG 20 (5), 1165, 2014 | 509 | 2014 |
| Probiotic lactobacilli and VSL# 3 induce enterocyte β-defensin 2 M Schlee, J Harder, B Köten, EF Stange, J Wehkamp, K Fellermann Clinical & Experimental Immunology 151 (3), 528-535, 2008 | 469 | 2008 |
| Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis J Wehkamp, J Harder, M Weichenthal, O Mueller, KR Herrlinger, ... Inflammatory bowel diseases 9 (4), 215-223, 2003 | 469 | 2003 |
